622 | P+R‐ICE: PEMBROLIZUMAB IN COMBINATION WITH R‐ICE CHEMOTHERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Documenti analoghi

• 828 | TRIAL IN PROGRESS: PEMBROLIZUMAB IN COMBINATION WITH SALVAGE CHEMOTHERAPY FOR FIRST‐RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (PEMBRO‐CORE)
  di: H. Tharmaseelan, et al.
  Pubblicazione: (2025)
• 666 | OUTCOMES OF RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA IN AN ASIAN MULTIETHNIC COHORT
  di: N. Lim, et al.
  Pubblicazione: (2025)
• 632 | EFFICACY AND SAFETY OF POLA‐ICE, WITH OR WITHOUT RITUXIMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: A REAL‐WORLD SINGLE CENTER STUDY
  di: H. Huang, et al.
  Pubblicazione: (2025)
• 421 | ctDNA DYNAMICS OF REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
  di: R. N. Rys, et al.
  Pubblicazione: (2025)
• 663 | PATIENT PREFERENCES FOR ATTRIBUTES OF BISPECIFIC ANTIBODIES INDICATED FOR THE TREATMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA IN THE UNITED STATES
  di: E. Mulvey, et al.
  Pubblicazione: (2025)